Diagnoptics News

What's new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

Diagnoptics receives Japanese market approval for AGE Reader mu.

Groningen, the Netherlands – September 11, 2015

Diagnoptics has received a Todokede registration from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for the AGE Reader mu in Japan. This allows Diagnoptics to market the AGE Reader mu in Japan as a General Medical Device (class I). 

This approval means entry to another important market for the AGE Reader mu. Japanese healthcare professionals are now allowed to use the AGE Reader mu in general clinical practice. The AGE Reader SU was already available in Japan for clinical research since 2009 and will continue to be available for this purpose.

Share this link on:

Latest news items

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.